Practice Ready Package
Whether you are an NP student preparing for rotations or a new NP entering practice, this package features the top diagnoses you need to know to feel confident treating patients. Build your knowledge base through this package curated by Dr. Fitzgerald.
Included Courses
Courses included in this package. Click on a course to learn more.
- Acute Asthma and COPD Exacerbations: An evidence-based approach to management 2 1Learn the latest evidence-based recommendations on assessment and intervention in acute asthma exacerbations from Dr. Fitzgerald, NP asthma expert and certified asthma educator.
- Anemia Assessment and Intervention: Common and Not So Common 1.8 1.8
Run Time: 1.5
Contact Hours: 1.8
Rx Hours: 1.8Award winning speaker Dr. Margaret Fitzgerald provides a concise review of the use of laboratory testing to confirm the diagnosis of anemia and investigate its underlying cause(s).
- Antibiotic Update: Community-acquired Pneumonia 1.75 1
This case-based course will help you gain an understanding of factors that influence the development of resistant pathogens and learn about the latest treatment recommendations.
- Bacterial Pharyngitis, Acute Bacterial Rhinosinusitis, Acute Otitis Media 2 2
What are the most common risk factors for acute bacterial pharyngitis, acute otitis media, and acute conjunctivitis? What are the leading pathogens causing these conditions?
- Case-based Approach to HTN Management: Combination Therapy is Essential 1.25 1.25Discover the critical role of combination therapy in achieving optimal blood pressure control and minimizing the risk of complications in this comprehensive program.
- Clinical Guideline Updates: anxiety, colorectal cancer (CRC), HIV and PrEP, COPD, OSA, and COVID-19 1 1Clinical practice guidelines play a crucial role in optimizing patient care, but keeping pace with their frequent updates can be challenging.
- Drug-Drug Interactions: Safe Prescribing to Avoid Malpractice 1.5 1.5
The course will focus on:
- Discuss the most common mechanisms for drug-drug interactions
- Discuss techniques to ensure safe prescribing to prevent malpractice
- Review cases involving prescribing errors and medical malpractice cases
- Evaluation in Immunologic and Autoimmune and Inflammatory Disorders 1.6 1.6
This program will help you understand the expected laboratory findings in autoimmune diseases. Included are the common laboratory findings in inflammatory disease including cardiovascular and infectious as well as rheumatoid arthritis and systemic lupus erythematosus.
- Fluid and Electrolyte Abnormalities: Evaluation and management of common disorders 2.75 2.75This program will provide the clinician with information relevant to the evaluation and management of common fluid and electrolyte disorders encountered in the adult and geriatric population in primary and acute care settings.
- Hepatic Function Assessment 2.1 0
Learn the appropriate use of laboratory testing as part of the evaluation process of the person with or at risk for hepatic dysfunction including drug-induced problems, acute and chronic infectious hepatitis. The program covers the clinical utility of commonly ordered hepatic laboratory tests such as hepatic enzymes, albumin, prothrombin time, bilirubin, and others, as part of the differential diagnosis process.
- Laboratory Diagnosis: Challenging Case Studies 1.2 0
Run Time: 1.3
Contact Hours: 1.2
Rx Hours: 0Laboratory testing often plays a key role in formulating and/or refining the differential diagnosis. This course presents challenging cases to help you refine your expertise in ordering and analyzing laboratory tests.
- Laboratory Diagnostics: A Focus on Renal Insufficiency and Failure 1.8 1.8
Dr. Margaret Fitzgerald will help you learn the common and not-so-common risk factors for renal disease, the pathophysiology in renal disease, and the expected laboratory findings in acute and chronic renal disorders.
- Laboratory Monitoring During Drug Therapy 1 1Laboratory monitoring plays a critical role in ensuring safe and effective medication therapy, enhance patient care and medication management with Laboratory Monitoring During Drug Therapy program presented by clinical expert Dr. Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP.
- Management of Thyroid Disorders: Too Many, Too Little, Masses 1.9 1.9
In this case-based program, award winning speaker and educator Dr. Margaret Fitzgerald discusses the most cost-effective tests to order in suspected thyroid disorders, recommended tests and imaging in the evaluation of a thyroid mass, evidence-based guidelines for intervention in common thyroid disorders and thyroid masses, and more.
- Opioid Prescribing: A comprehensive approach to legislative and practice issues 5 5
Pharmacology expert Dr. Miller provides a detailed approach to opioid prescribing issues for NPs. Legislative considerations; national, evidence-based guidelines; and pharmacology of opioid prescribing are explored.
- RX Essentials: Diabetes Update: Focus on the latest recommendations 1.5 1.5Effectively managing type 2 diabetes requires keeping pace with evolving evidence and innovative approaches. Join clinical expert Dr. Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP for an in-depth exploration of the latest recommendations in managing type 2 diabetes.
- UTI in Adults: Update on Assessment & Treatment & Asymptomatic Bacteriuria 1.6 1.6
What are the most likely urinary tract infection (UTI) organisms? What are the most common UTI risk factors? What are the current recommendations for assessment and treatment of UTI? Learn the answers to these questions in this evidence-based program.
- Vitamin D Deficiency: Assessment & Intervention 1.25 0.25
Is vitamin D a vitamin or a hormone? Is vitamin D deficiency the cause of a multitude of illnesses, or is it a source of hype? Learn the answers to these questions from expert clinician, Dr. Margaret Fitzgerald.
- WBC Count and Differential 1.5 0
Run Time: 1.3
Contact Hours: 1.5
Rx Hours: 0This course will enable you to identify the function of the white blood cells as well as assessing the WBC with differential during acute bacterial infectious disease and infection recovery.
- What's New with AHA/ACC Guidelines for the Management of Lipid Disorders? 1.5 1.5This program presents the most current guideline updates and pharmacologic options for lipid management recommended by the American College of Cardiology/American Heart Association. With a focus on atherosclerotic cardiovascular disease risk reduction, medical history, lipid panel, and CAC scoring are analyzed. Building upon the HMG-CoA reductase inhibitors, additional therapeutic agents for the high-risk patient are considered, with the latest evidence-based analysis of indication, risk, and safety. Cholesterol absorption inhibitors, PCSK9 inhibitors, and ACL inhibitors are all explored as they apply to current guideline-driven management.